Thursday, March 19, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Intel Shares Attract Insider Buying Amid Divergent Market Views

Robert Sasse by Robert Sasse
January 31, 2026
in Analysis, Insider Trading, Nasdaq, Semiconductors, Tech & Software
0
Intel Stock
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

The investment case for Intel Corporation currently presents a tug-of-war between immediate concerns and long-term potential. Recent cautious guidance from the chipmaker has unsettled many shareholders, yet this has been met with notable confidence from both within the company’s leadership and certain corners of Wall Street, suggesting the current valuation may present an opportunity.

Management Demonstrates Conviction with Personal Investment

A significant vote of confidence has come directly from Intel’s executive suite. David Zinsner, the company’s Executive Vice President and Chief Financial Officer, capitalized on recent share price levels to make a substantial personal purchase. He acquired 5,882 Intel shares at an average price of $42.50, representing a total investment of approximately $250,000. Transactions of this nature are closely scrutinized by the market, as they are interpreted as a signal of perceived undervaluation from those with the deepest operational insight.

Analyst Stakes a Bullish Claim Against the Consensus

Amid prevailing market skepticism, investment firm Tigress Financial Partners has adopted a contrarian stance. On January 28, the firm reaffirmed its “Buy” rating on Intel and raised its price target to $66. Analyst Ivan Feinseth bases this optimistic outlook on the company’s structural improvements, particularly within its artificial intelligence strategy.

Key drivers cited include advancements in AI data center offerings and the development of the new 18A manufacturing process. Feinseth anticipates the upcoming cycle of AI-enabled PCs, expected to gain momentum through 2026, will provide additional revenue growth. This perspective contrasts with the broader analyst consensus urging caution but finds some support from market commentator Jim Cramer, who highlighted Intel’s strengthened balance sheet.

Should investors sell immediately? Or is it worth buying Intel?

Cautious Guidance Weighs on Near-Term Sentiment

The backdrop for investor hesitation stems from the company’s own forecasts. While Intel’s fourth-quarter 2025 revenue of $13.67 billion surpassed expectations, its outlook for the first quarter of 2026 proved disappointing. Management anticipates a revenue decline and adjusted results that will only break even.

This soft guidance has dampened sentiment, fueling concerns over near-term profitability during a costly strategic transformation period. Intel’s stock closed the recent trading week at $47.31, marking a daily decline of 1.74%.

The Pivotal Long-Term Bet

The future trajectory for Intel appears to hinge on the success of its bid to reclaim technology leadership. The company has installed the first commercial High-NA EUV lithography machine, underscoring its ambition to return to the forefront of chip manufacturing by 2027/28. However, the path is not without potential hurdles; rumors suggest Nvidia may forgo the 18A process following tests, while speculation persists about potential interest from Apple in Intel’s foundry capacity. The coming quarters will be critical in determining whether Intel’s substantial investments can translate into sustainable competitive advantage and financial performance.

Ad

Intel Stock: Buy or Sell?! New Intel Analysis from March 18 delivers the answer:

The latest Intel figures speak for themselves: Urgent action needed for Intel investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 18.

Intel: Buy or sell? Read more here...

Tags: Intel
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

InMed Pharmaceuticals Stock
Analysis

InMed Pharmaceuticals: The Critical Search for Clinical Validation

March 18, 2026
Merchants Trust - 3.65% Prf Perpetual Gbp 1 Stock
Analysis

Merchants Trust Publishes Latest Net Asset Value Figures

March 18, 2026
Traverse Energy Stock
Analysis

Traverse Energy: A Company in Strategic Limbo

March 18, 2026
Next Post
Franklin FTSE India ETF Stock

India's ETF Landscape: Currency Weakness Tests Franklin Fund Resilience

American Electric Power Stock

American Electric Power's Infrastructure Investment Takes Center Stage

Aemetis Stock

Aemetis Unveils New Capital Strategy and Operational Milestones for 2026

Recommended

aTyr Pharma Stock

Clinical Trial Failure Sends aTyr Pharma Shares into Freefall

6 months ago
Pepsi Stock

Activist Investor Elliott Takes $4 Billion Stake in PepsiCo, Demands Strategic Overhaul

6 months ago
Melco Resorts, Entertainment Stock

Melco Resorts’ Strategic Pivot Fuels Impressive Stock Surge

3 months ago
Storefront

How to Find an Amazon Storefront: A Comprehensive Guide

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

A Pivotal Tax Change Looms for Bitcoin Staking ETP Investors

InMed Pharmaceuticals: The Critical Search for Clinical Validation

Merchants Trust Publishes Latest Net Asset Value Figures

Traverse Energy: A Company in Strategic Limbo

Nel ASA Embraces Digital Shift with Virtual Annual Meeting

Infineon’s Strategic Pivot Amid Rising Asian Competition in Power Semiconductors

Trending

PPI Shock, $109 Brent, and the Afternoon Powell Has No Good Answers
Newsletter

PPI Shock, $109 Brent, and the Afternoon Powell Has No Good Answers

by Stephanie Dugan
March 18, 2026
0

Dear readers, Yesterday we told you the equity market's composure rested on a bet that demanded near-perfect...

Advance United Holdings Stock

Strengthening Market Presence: Advance United Holdings Engages Liquidity Provider

March 18, 2026
VERSAMET Stock

Versamet Posts Record Financial Performance in 2025

March 18, 2026
1valour Btc Physical Staking Stock

A Pivotal Tax Change Looms for Bitcoin Staking ETP Investors

March 18, 2026
InMed Pharmaceuticals Stock

InMed Pharmaceuticals: The Critical Search for Clinical Validation

March 18, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • PPI Shock, $109 Brent, and the Afternoon Powell Has No Good Answers
  • Strengthening Market Presence: Advance United Holdings Engages Liquidity Provider
  • Versamet Posts Record Financial Performance in 2025

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com